ADCT ADC Therapeutics SA Forecast, Technical & Fundamental Analysis

Industry Biotechnology

Get AI intraday signals

ADCT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ADCT
(Try 14 days for Free)

View a ticker or compare two or three

Compare

ADCT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ADCT
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

ADCT is expected to report earnings to rise 38.68% to -38 cents per share on March 13

ADC Therapeutics SA ADCT Stock Earnings Reports

Q4'24

Est.

$-0.39

Q3'24

Beat

by $0.10

Q2'24

Beat

by $0.08

Q1'24

Beat

by $0.17

Q4'23

Missed

by $0.51

The last earnings report on November 07 showed earnings per share of -28 cents, beating the estimate of -37 cents. With 478.22K shares outstanding, the current market capitalization sits at 256.23M.

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Route de la Corniche 3B

Phone

+41 216530200

Employees

274

Web

https://www.adctherapeutics.com

Interesting Tickers

STOCK / NAME	Price $	Chg $	Chg %
		1 Day
GME	27.37	0.91	+3.44%
GameStop Corp
AAPL	228.22	3.10	+1.38%
Apple
SPY	593.35	-3.84	-0.64%
SPDR® S&P 500® ETF Trust
BTC.X	87250.430000	-3333.734400	-3.68%
Bitcoin cryptocurrency
TSLA	311.18	-19.06	-5.77%
Tesla

ADCT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with CCCC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then CCCC could also see price increases.

Ticker / NAME	Correlation To ADCT	1D Price Change %
ADCT	100%	-6.03%
CCCC - ADCT	44% Loosely correlated	-7.99%
STTK - ADCT	42% Loosely correlated	+12.30%
PRME - ADCT	41% Loosely correlated	-9.22%
ACAD - ADCT	41% Loosely correlated	-3.24%
MLYS - ADCT	40% Loosely correlated	-2.25%
More